Dr Ruby Lin joined the ADRI in May 2014 from the Ramaciotti Centre for Genomics. She completed PhD in 2003 and has been awarded >A$2.5m in competitive funding including as CI on 3 NHMRC project grants (most recently 2013-5, McMullen & Lin), ARC LIEF and a Cancer Institute Infrastructure Grant in 2005. She has 4 seminal papers in Nature, 2010, ATVB, 2010, PNAS, 2012 and Faseb J, 2014, all received media coverage. She has presented >57 papers at >25 conferences and cross-discipline seminars as invited chair and speaker (AGTA2013, HBPRCA’09, AGTA’09, ASMR’09, Lorne Genome2004). The 4 societies are at the forefront of genomic technologies, cardiovascular and medical research in Australasia. She is now the president of Australasian Genomic Technologies Association (AGTA), a prominent society in genomics in Australasia. She is an inventor on 2 patents and collaborates with Santaris Pharma, the leading company in the world for RNA therapeutic technologies. She was a Peter Doherty fellow, 2005-8 and a UNSW fellow 2009-14.